EPHA2 and pancreatic neoplasm: Van Geer et al. reported a lack of EphA2-mediated adenoviral tumor transduction in vivo when injecting their double-ablated YSA Ads i.v. or i.p. into mice with xenografts of pancreatic cancer cells [53].